Long-Term Treatment of Hyperphosphatemia With Bixalomer in Japanese Hemodialysis Patients-Reference-Cited by-同舟云学术

Long-Term Treatment of Hyperphosphatemia With Bixalomer in Japanese Hemodialysis Patients

Published:2013-03-11 Issue:6 Volume:17 Page:612-619
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Akizawa Tadao¹,Kameoka Chisato²,Kaneko Yuichiro²,Kawasaki Shigenori²,

Affiliation:

1. Division of Nephrology; Department of Medicine; Showa University School of Medicine; Tokyo Japan

2. Astellas Pharma Inc.; Tokyo Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Reference16 articles.

1. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis;Block;J Am Soc Nephrol,2004

2. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients;Noordzij;Nephrol Dial Transplant,2011

3. Association of elevated serum PO(4), Ca×PO (4)product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients;Ganesh;J Am Soc Nephrol,2001

4. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Pattern Study;Young;Kidney Int,2005

5. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population;Floege;Nephrol Dial Transplant,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a review of safety profiles;Expert Opinion on Drug Safety;2022-02-21

2. CKD-MBDとは ; 概念の構築と変遷;Nihon Toseki Igakkai Zasshi;2018

3. Pharmacotherapy in chronic kidney disease hyperphosphatemia – effects on vascular calcification and bone health;Macedonian Pharmaceutical Bulletin;2017-12-31

4. Long-Term Safety and Efficacy of Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis;Therapeutic Apheresis and Dialysis;2017-02-14

5. Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis: Phase 3 Randomized Trial;Therapeutic Apheresis and Dialysis;2016-11-29